APA (7th ed.) Citation

CL, B., DM, B., PA, U., SD, R., & MK, K. (2026). Economic evaluation of added neoadjuvant cemiplimab to upfront wide local excision for advanced cutaneous squamous cell carcinoma of the head and neck. JID innovations : skin science from molecules to population health, 6(5), 100501. https://doi.org/10.1016/j.xjidi.2026.100501

Chicago Style (17th ed.) Citation

CL, Bailey-Burke, Brizel DM, Ubel PA, Reed SD, and Kheterpal MK. "Economic Evaluation of Added Neoadjuvant Cemiplimab to Upfront Wide Local Excision for Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck." JID Innovations : Skin Science from Molecules to Population Health 6, no. 5 (2026): 100501. https://doi.org/10.1016/j.xjidi.2026.100501.

MLA (9th ed.) Citation

CL, Bailey-Burke, et al. "Economic Evaluation of Added Neoadjuvant Cemiplimab to Upfront Wide Local Excision for Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck." JID Innovations : Skin Science from Molecules to Population Health, vol. 6, no. 5, 2026, p. 100501, https://doi.org/10.1016/j.xjidi.2026.100501.